Stifel on Thursday initiated coverage on Immunic Inc. IMUX, a late-stage biotechnology company developing oral therapies for ...
Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech ...
Quantum Biopharma has filed with the FDA to start a Phase 2 trial of Lucid-MS to assess the treatment's ability to halt disease progression.
Longtime runner Annie Saunders didn’t let a 2021 diagnosis of multiple sclerosis sideline her passions. If anything, the 40-year-old Irwin native pushes harder — through weakness and imbalance caused ...
In the coming weeks, Quantum Biopharma will seek FDA permission for a clinical trial testing Lucid-MS, its therapy to slow myelin loss in MS.
Cancer therapeutics and orphan drugs are no longer niche areas. Specialty drugs are now a significant portion of the ...
A Mitchell woman with a long history of drug-related offenses was sentenced Tuesday afternoon after violating the terms of ...
Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...
Immunic, Inc. (Nasdaq: IMUX), a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic diseases, today announced participation in the following scientific a ...
Her vibrant yet brooding work explored the crises of the Trump era, with paintings depicting the Jan. 6 riots and a mangled ...
Ad Scientiam Launches U.S. Subsidiary And Expands Deployment Of Mscopilot® Following FDA Registration. EINPresswire/ -- Ad Scientiam, a global leader in digital biomarkers, today announced the ...
PRESS RELEASEAB SCIENCE PROVIDES AN UPDATE ON ITS CLINICAL PROGRAM AB SCIENCE SECURES EUR 25 MILLION CLINICAL TRIAL INSURANCE FOR ITS PHASE III ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results